Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Unearned Compensation
Beginning balance (in shares) at Dec. 31, 2023   24,850,261        
Beginning balance at Dec. 31, 2023 $ 14,652,295 $ 24,850 $ 57,601,402 $ (42,879,656) $ (94,301) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Distributions to non-controlling interest (96,975)       (96,975)  
Stock based compensation expense 131,906   131,906      
Net (loss) income (3,494,022)     (3,574,171) 80,149  
Ending balance (shares) at Sep. 30, 2024   24,850,261        
Ending balance at Sep. 30, 2024 11,193,204 $ 24,850 57,733,308 (46,453,827) (111,127) 0
Beginning balance (in shares) at Jun. 30, 2024   24,850,261        
Beginning balance at Jun. 30, 2024 12,095,547 $ 24,850 57,691,400 (45,523,419) (97,284) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Distributions to non-controlling interest (48,321)       (48,321)  
Stock based compensation expense 41,908   41,908      
Net (loss) income (895,930)     (930,408) 34,478  
Ending balance (shares) at Sep. 30, 2024   24,850,261        
Ending balance at Sep. 30, 2024 11,193,204 $ 24,850 57,733,308 (46,453,827) (111,127) 0
Beginning balance (in shares) at Dec. 31, 2024   24,950,261        
Beginning balance at Dec. 31, 2024 10,125,538 $ 24,950 57,845,289 (47,639,894) (104,807) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Follow-on offering, net of transaction costs (in shares)   3,985,000        
Follow-on offering, net of transaction costs 18,105,100 $ 3,985 18,101,115      
Issuance of restricted stock awards (in shares)   95,808        
Issuance of restricted stock awards $ 0 $ 96 799,901     (799,997)
Exercise of stock options (in shares) 547,654 547,654        
Exercise of stock options $ 658,403 $ 548 657,855      
Distributions to non-controlling interest (42,956)       (42,956)  
Related party note conversion to common stock (in shares)   240,256        
Related party note conversion to common stock 514,148 $ 240 513,908      
Stock based compensation expense 209,858   172,153     37,705
Net (loss) income (4,252,710)     (4,254,974) 2,264  
Ending balance (shares) at Sep. 30, 2025   29,818,979        
Ending balance at Sep. 30, 2025 25,317,381 $ 29,819 78,090,221 (51,894,868) (145,499) (762,292)
Beginning balance (in shares) at Jun. 30, 2025   25,571,490        
Beginning balance at Jun. 30, 2025 8,941,451 $ 25,571 58,837,181 (49,763,921) (157,380) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Follow-on offering, net of transaction costs (in shares)   3,985,000        
Follow-on offering, net of transaction costs 18,105,100 $ 3,985 18,101,115      
Issuance of restricted stock awards (in shares)   95,808        
Issuance of restricted stock awards 0 $ 96 799,901     (799,997)
Exercise of stock options (in shares)   166,681        
Exercise of stock options 263,477 $ 167 263,310      
Stock based compensation expense 126,419   88,714     37,705
Net (loss) income (2,119,066)     (2,130,947) 11,881  
Ending balance (shares) at Sep. 30, 2025   29,818,979        
Ending balance at Sep. 30, 2025 $ 25,317,381 $ 29,819 $ 78,090,221 $ (51,894,868) $ (145,499) $ (762,292)